NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.

Stockholm, Dec 13, 2024

ContextVision AB (publ) ("ContextVision" or the "Company") hereby launches an offer to buy back up to 3,000,000 shares in the Company for an amount up to NOK 15,000,000 (the "Offer"). The purpose of the Offer is to acquire shares for use in connection with the Company's Long-Term Incentive Program and/or to reduce the capital of the Company. The Offer will be carried out based on the authorisation granted to the board of directors at the Extraordinary General Meeting held on November 20, 2024.

The Offer will be conducted as a reversed book-building process where the Company, through Carnegie AS ("Carnegie"), will receive offers for desired volumes for sale from the shareholders. All shareholders in the Company are invited to sell shares in connection with the Offer, subject to the restrictions set out herein.

The Company has mandated Carnegie as bookrunner for the Offer and shareholders with interest to sell shares may contact Carnegie via email contextvision@carnegie.no or by phone +47 22 00 93 40 before the end of the Application Period (as defined below).

The Offer starts on December 16th, 2024 at 09:00 CET and will close no later than December 17th, 2024 at 16:30 CET (the «Application Period»). The final price offered by the Company and the allocation of tendered shares are expected to be resolved by the Company on or about December 17th, 2024. The trade date is expected to be on or about December 17th, 2024 and the settlement date is expected to be on or about December 18th, 2024. The settlement will be conducted on a normal delivery-versus-payment basis. The Company reserves the right to extend the Application Period at its own discretion. If the Application Period is extended, the other dates referred to herein may be amended accordingly.

The final purchase price per share will be set based on the sales orders received at a level representing a satisfactory price and offering volume. The purchase price per share shall not exceed NOK 10 or be less than NOK 5. The final purchase price will be identical for all selling shareholders.

The Company will in the event of receiving offers exceeding a total of 3,000,000 shares, allocate shares at its discretion in accordance with the best interest of the Company, taking into account the prices and volumes offered, with equal treatment of the shareholders as the primary objective.

The Company reserves the right to, at its own discretion buy back fewer shares or no shares at all, to terminate the Offer or make any amendments regarding the volume or other terms of the Offer at any time until the time of completion of the Offer.

This stock exchange announcement is published in accordance with the disclosure requirements in Section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Richard Hallström, CFO, on the time and date provided.

For more information, please contact:

Richard Hallström, CFO richard.hallstrom@contextvision.com

About the ContextVision

ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X -ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.